The abstract is read at the publisher; the summary is JClub's.
ARB therapy is linked to lower risks of headache and new-onset diabetes, and to lower fasting plasma insulin levels, across umbrella-reviewed RCT meta-analyses.
- Why it matters: The broader effects of angiotensin receptor blockers on nontraditional outcomes are unclear, despite widespread use, creating uncertainty for clinical decision-making beyond cardiovascular and renal protection.
- What they did: An umbrella review searched PubMed, Embase, Cochrane Library, and Web of Science to April 2026 for systematic reviews and meta-analyses of RCTs, appraising quality with AMSTAR 2 and certainty with GRADE, and re-analysing trial-level data when available.
- The result: Among 35 unique nontraditional outcomes, nine were nominally significant, but only a few met stricter credibility criteria; no convincing evidence supported oncological, infectious, or transplant-related associations, and most included reviews were low or critically low quality.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.